BD, BioGX announce FDA EUA for COVID-19 dx

Create PDF

April 3, 2020—BD and BioGX announced that the FDA has granted emergency use authorization for a diagnostic test that will enable hospitals to screen for COVID-19 on site and get results in less than three hours.